EMA proposes new guideline on model-informed drug development
Regulatory NewsJoanne S. Eglovitch
EuropeEuropean Medicines Agency (EMA)Modeling and simulationPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchEuropeEuropean Medicines Agency (EMA)Modeling and simulationPharmaceuticalsProduct developmentRegulatory Intelligence/Policy